Homepage
FRESH Analysis Report
Jun 7, 2026
5 days ago · 96% complete · +6 refreshed

Primo Brands Corporation

PRMB NYSE Categories PDF
Consumer Defensive · Beverages - Non-Alcoholic
Tampa, FL 33607, United States IPO 2024 primowatercorp.com Updated Jun 7, 3:57pm
Price
$22.95
Market Cap
$8.3B
Employees
13,000
Beta
0.71
Avg Volume
4,338,638
CEO
Eric J. Foss
Business Description

Primo Water Corporation provides water direct to consumers and water filtration services in North America and Europe. It offers bottled water, purified bottled water, premium spring, sparkling and flavored water, mineral water, filtration equipment, and coffee; as well as water dispensers, and self-service refill drinking water. The company offers its products under the Primo, Alhambra, Crystal Rock, Mountain Valley, Deep Rock, Hinckley Springs, Crystal Springs, Kentwood Springs, Mount Olympus, Pureflo, Nursery, Sierra Springs, Sparkletts, Clear Mountain Natural Spring Water, Earth2O, Renü, Water Event Pure Water Solutions, Canadian Springs, Labrador Source, Decantae, Eden, Eden Springs, Chateaud'eau, and Mey Eden brands. It provides its services to residential customers, small and medium-sized businesses, and regional and national corporations and retailers. The company was formerly known as Cott Corporation and changed its name to Primo Water Corporation in March 2020. Primo Water Corporation was incorporated in 1955 and is headquartered in Tampa, Florida.

Business History
Generated: Jun 7, 2026 4:00pm
Price Overview
Last updated: Jun 7, 2026 3:57pm (5d ago)
$22.95
-0.07 (-0.30%)
Day Range
$22.83 – $23.39
52-Week Range
$14.36 – $31.49
50-Day MA
$21.09
200-Day MA
$20.23
Volume
3,476,158.00
Analyst Price Targets
Low $24.00
Consensus $27.17
High $35.00
(14 analysts)
Share Structure
Outstanding 362,868,562.00
Float 242,381,685.00
Free Float 66.8%
Normal free float — 66.8% of shares trade freely, ~33.2% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Last updated: Jun 7, 2026 4:03pm (5d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jun 7, 2026 4:03pm (5d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
Industry comparison last run: Jun 7, 2026 3:59pm
P/E Ratio (Price per dollar of earnings)
API
Stock Price / EPS (Diluted)
142.15
Stock Price: $22.95
EPS (Diluted): 0.16
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
2.04
Stock Price: $22.95
Total Equity: $2.99B
Shares: 374,869,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
12.41
Market Cap: $8.33B
Total Debt: $5.12B
Cash: $376.90M
EBITDA: $1.08B
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$11.5B
Market Cap: $8.33B
Total Debt: $5.12B
Cash: $376.90M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
32.2%
Gross Profit: $2.14B
Revenue: $6.66B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
11.3%
Operating Income: $751.50M
Revenue: $6.66B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
0.9%
Net Income: $60.10M
Revenue: $6.66B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
1.9%
Net Income: $60.10M
Total Equity: $2.99B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
3.1%
Operating Income: $751.50M
Tax Rate: 44.6%
Equity: $2.99B
Total Debt: $5.12B
Cash: $376.90M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
0.95
Current Assets: $1.22B
Current Liabilities: $1.28B
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
1.71
Short-Term Debt: $166.20M
Long-Term Debt: $4.95B
Total Debt: $5.12B
Total Equity: $2.99B
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$17.78
Revenue: $6.66B
Shares: 374,869,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$7.98
Total Equity: $2.99B
Shares: 374,869,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$0.83
Operating CF: $687.40M
CapEx: -$377.40M
Shares: 374,869,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
2.5%
Last Dividend: N/A
Stock Price: $22.95
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: $60.10M
Dividends paid not available in cash flow statement
Industry Benchmarks
Last run: Jun 7, 2026 3:59pm
Compares PRMB against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis
Last run: Jun 7, 2026 4:03:24 pm

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
Not applicable for High Growth Profitable companies
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
Not applicable for High Growth Profitable companies
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
Not applicable for High Growth Profitable companies
4h Dividend Discount Model — For dividend/income stocks only
Not applicable for High Growth Profitable companies
4i Book Value Analysis — For deep value / turnaround stocks only
Not applicable for High Growth Profitable companies
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
Not applicable for High Growth Profitable companies
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 7, 2026 4:03pm (5d ago)
Metric 2021 2022 2023 2024 2025
Revenue $2.1B $1.7B $4.7B $5.2B $6.7B
Cost of Revenue $915.9M $674.0M $3.3B $3.5B $4.5B
Gross Profit $1.2B $1.0B $1.4B $1.6B $2.1B
Operating Expenses $1.0B $883.8M $929.1M $1.1B $1.4B
Operating Income $125.5M $135.4M $422.9M $564.4M $751.5M
Net Income -$3.2M $29.6M $92.8M -$16.4M $60.1M
EBITDA $294.2M $328.0M $711.7M $693.6M $1.1B
EPS $-0.02 $0.18 $0.40 $-0.07 $0.16
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jun 7, 2026 4:00pm (5d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $128.4M $78.8M $47.0M $614.4M $376.9M
Total Current Assets $509.8M $538.0M $698.0M $1.5B $1.2B
Total Assets $3.7B $3.7B $5.2B $11.2B $10.6B
Current Liabilities $709.8M $690.6M $782.8M $1.4B $1.3B
Long-Term Debt $1.2B $1.2B $3.4B $4.9B $5.0B
Total Liabilities $2.4B $2.4B $5.2B $7.8B $7.6B
Total Equity $1.3B $1.3B $2.7M $3.4B $3.0B
Retained Earnings $16.4M -$9.4M -$1.0B -$1.5B -$2.0B
Cash Flow (Annual)
Last updated: Jun 7, 2026 4:03pm (5d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $247.1M $281.6M $320.9M $467.2M $687.4M
Capital Expenditure -$152.0M -$162.1M -$203.6M -$150.2M -$377.4M
Free Cash Flow $95.1M $119.5M $117.3M $317.0M $310.0M
Acquisitions (net) -$81.5M $42.7M $0 $0 -$29.0M
Debt Repayment
Dividends Paid
Stock Buybacks -$48.1M -$27.7M -$183.6M -$10.4M -$421.5M
Net Change in Cash $13.3M -$49.6M -$31.8M $567.4M -$237.5M
Analyst Estimates (Annual)
Last updated: Jun 7, 2026 3:57pm (5d ago)
Metric 2027 2028 2029 2030
Revenue $7.0B
$7.0B – $7.1B
$7.3B
$7.2B – $7.3B
$7.6B
$7.5B – $7.6B
$7.8B
$7.8B – $7.9B
EBITDA $1.1B
$1.1B – $1.1B
$1.1B
$1.1B – $1.1B
$1.2B
$1.2B – $1.2B
$1.2B
$1.2B – $1.2B
Net Income $556.1M
$472.1M – $640.1M
$653.4M
$646.7M – $660.0M
$772.2M
$764.9M – $780.6M
$862.2M
$854.0M – $871.6M
EPS
Growth Trends (YoY %)
Last updated: Jun 7, 2026 4:03pm (5d ago)
Metric 2022 2023 2024 2025
Revenue Growth -18.3% +177.5% +9.7% +29.3%
Gross Profit Growth -11.9% +32.7% +19.9% +32.2%
Operating Income Growth +7.9% +212.3% +33.5% +33.2%
Net Income Growth +1,025.0% +213.5% -117.7% +466.5%
EBITDA Growth +11.5% +117.0% -2.5% +56.0%
Insider Trading (Recent)
Last updated: Jun 7, 2026 4:01pm (5d ago)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-05-15 Brimmer Andrea C A-Award 7,197.00 $0.00 $0
2026-05-15 Brimmer Andrea C 0.00 $0.00 $0
2026-04-28 Cates Susan E. A-Award 8,887.00 $0.00 $0
2026-04-28 STANBROOK STEVEN P A-Award 8,887.00 $0.00 $0
2026-04-28 PAK MINSOK A-Award 8,887.00 $0.00 $0
2026-04-28 Cramer Michael John A-Award 8,887.00 $0.00 $0
2026-04-28 Fowden Jeremy SG A-Award 8,887.00 $0.00 $0
2026-04-28 Metropoulos C. Dean A-Award 429.00 $19.69 $8,447
2026-04-28 Bomhard Britta A-Award 8,887.00 $0.00 $0
2026-04-28 Prim Billy D A-Award 8,887.00 $0.00 $0
2026-03-31 Metropoulos C. Dean A-Award 1,460.00 $18.83 $27,492
2026-03-31 STANBROOK STEVEN P A-Award 1,593.00 $18.83 $29,996
2026-01-23 Hass David W. F-InKind 2,719.00 $19.26 $52,368
2026-01-15 PAK MINSOK A-Award 2,683.00 $0.00 $0
2026-01-15 PAK MINSOK 0.00 $0.00 $0
2026-01-03 Ausher Jason R F-InKind 3,814.00 $16.19 $61,749
2026-01-03 Hass David W. F-InKind 18,052.00 $16.19 $292,262
2025-12-31 STANBROOK STEVEN P A-Award 2,193.00 $16.35 $35,856
2025-12-31 Metropoulos C. Dean A-Award 1,681.00 $16.35 $27,484
2025-12-10 FOSS ERIC J A-Award 129,770.00 $0.00 $0
Dividend History (Last 20)
Last updated: Jun 7, 2026 3:57pm (5d ago)
Date Dividend Declaration Record Payment
2026-06-04 $0.12 2026-04-29 2026-06-04 2026-06-15
2026-03-06 $0.12 2026-02-19 2026-03-06 2026-03-23
2025-11-25 $0.10 2025-11-06 2025-11-25 2025-12-05
2025-08-21 $0.10 2025-08-07 2025-08-21 2025-09-04
2025-06-06 $0.10 2025-05-01 2025-06-06 2025-06-17
2025-03-07 $0.10 2025-02-20 2025-03-07 2025-03-24
2024-11-22 $0.09 2024-11-08 2024-11-22 2024-12-05
2024-11-05 $0.82 2024-10-15 2024-11-05 2024-11-21
2024-08-22 $0.09 2024-08-07 2024-08-22 2024-09-05
2024-06-07 $0.09 2024-05-09 2024-06-07 2024-06-18
2024-03-07 $0.09 2024-02-22 2024-03-08 2024-03-25
2023-11-20 $0.08 2023-11-02 2023-11-21 2023-12-01
2023-08-23 $0.08 2023-08-10 2023-08-24 2023-09-07
2023-06-01 $0.08 2023-05-04 2023-06-02 2023-06-14
2023-03-09 $0.08 2023-02-22 2023-03-10 2023-03-27
2022-11-28 $0.07 2022-11-09 2022-11-29 2022-12-09
2022-08-23 $0.07 2022-08-10 2022-08-24 2022-09-07
2022-06-09 $0.07 2022-05-11 2022-06-10 2022-06-22
2022-03-10 $0.07 2022-02-23 2022-03-11 2022-03-28
2021-11-22 $0.06 2021-11-03 2021-11-23 2021-12-03
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for PRMB.
Advanced Analysis Forensic deep-dive · two lenses
Two separate reads — Company Quality (is it a great business?) and Valuation (is it mispriced?), kept deliberately apart · 2026-06-07 17:01:27
Delvantic - Cairn AI
Fairly priced leveraged roll-up — wait for sub-$19 7/10
Real water-delivery franchise at a full price — quality is mixed (-29) and valuation is fair-to-full (-46), so this is a watch-list name, not a buy here.
The cruxWhether post-merger FCF can step from ~$310M toward $400M+ fast enough to outrun the leverage and the 375M share count — and I don't need to guess at $22.95.
Company Quality
-29
Mixed
edge √Σ 103 · risk √Σ 131 · conf 6/10
Valuation / Mispricing
-46
Fairly Valued
edge √Σ 36 · risk √Σ 82 · conf 6/10
Liquidity & RunwaySelf-Funding
DilutionHeavy Dilution
Earnings QualityAdequate / Mixed
The Play — combined read across both lenses Delvantic - Cairn AI

Both lenses are telling me the same thing from different angles. Quality at -29 says this is a real but leveraged roll-up still digesting BlueTriton — $310M FCF is trustworthy, everything else (GAAP earnings, margin structure, share count) is still settling. Valuation at -46 says 27× FCF on an $8.3B cap already prices in the consolidation/synergy bull case, and the merger debt makes EV/FCF worse than it looks. There's no edge in paying a staples multiple for non-staples-quality margins on a balance sheet sitting in Altman distress zone. The setup where I'd be wrong is fast synergy capture lifting FCF to $400M+, but I don't have to underwrite that at today's price — the market already is.

My play: zero position here, put it on the sheet with an alert at $19 and a real buy zone sub-$18.50 (the value lens's attractive-below line), conditional on FCF run-rate holding $300M+ and net debt actually coming down. At $18 with confirmed deleveraging I'd take a 1.5–2% starter and scale to 3–4% on a second leg lower or a clean post-integration quarter. Above $22 I'm not interested; chasing this into the low-$20s is paying full price for execution risk on a name where the per-share math is structurally diluted. Discipline call — patience, not conviction.

The evidence behind each score — switch lenses
-29 Mixed edge √Σ 103 · risk √Σ 131 · conf 6/10

Primo Brands is the product of the Primo Water / BlueTriton merger, and the financials show it: revenue jumped from $1.69B (2022) to $4.70B (2023) to $6.66B (2025), with gross margin resetting from ~60% pre-merger to ~32% post-merger and operating margin expanding from 6% (2021) to 11.3% (2025). FCF is genuine and rising — $310M in 2025 on top of $317M in 2024 — and the business clearly self-funds at the operating level. As a regional bottled-water + delivery operator (Poland Spring, Deer Park, Mountain Valley, Primo, etc.), the franchise has scale and recurring volume, which is a defensible if not elite consumer-staples profile.

The quality concerns are structural. Net debt of ~$4.74B against $377M cash and ~$610M of normalized net income gives an Altman Z of 1.25 (distress zone for an asset-heavy bottler), and diluted shares went from 160.6M (2023) to 242.3M (2024) to 374.9M (2025) — a 23.6% CAGR that reflects merger consideration rather than ongoing SBC abuse (SBC is only 0.8% of revenue, buyback/SBC 1350%). Still, per-share value creation lags reported growth dramatically: 2025 net income of $60M across 375M shares is only ~$0.16/sh, and the OCF/NI ratio of -16x reflects how noisy GAAP earnings are versus the cleaner ~$310M FCF.

Insider activity is almost entirely director equity awards (A-codes); the lone open-market purchases by Metropoulos (~$36K total) are small enough to be symbolic rather than a conviction signal — the 'significant insider buying' framing overstates it. Net-net: a credible, cash-generating staples operator with real scale, but levered and digesting a transformational merger, with earnings quality and per-share math both still unproven post-deal.

Strengths 4
m70
Consistent and growing free cash flow
FCF of $95M → $120M → $117M → $317M → $310M shows the combined entity is reliably cash-generative; 2025 FCF of $310M on $6.66B revenue is ~4.7% FCF margin, decent for a bottler.
m55
Operating margin expansion
Op margin climbed from 6.1% (2021) to 11.3% (2025), and held up through the BlueTriton integration — suggests merger synergies are landing rather than dissipating.
m45
Scaled brand portfolio in a defensive category
$6.66B revenue across Poland Spring/Deer Park/Mountain Valley/Primo gives regional density in water — a category with recurring demand and route-based moats.
m25
Low cash SBC
SBC at only 0.8% of revenue and buyback/SBC ratio of 1350% indicate the dilution is M&A-driven, not ongoing comp-driven leakage.
Concerns 5
m80
Heavy leverage / distress-zone Altman Z
Net debt of $4.74B vs. $377M cash and ~$310M FCF; Altman Z of 1.25 sits in the classical distress zone. Deleveraging will absorb FCF for years.
m75
Massive share count expansion
Diluted shares went 160.6M → 242.3M → 374.9M in two years (23.6% CAGR). Even if merger-related rather than abusive, per-share value creation is structurally diluted — 2025 EPS is only ~$0.16.
m55
Volatile/weak GAAP earnings quality
Net income oscillates: -$3M, +$30M, +$93M, -$16M, +$60M. OCF/NI of -16x and accruals at -5.7% of assets suggest large non-cash and merger-accounting items dominate reported earnings — GAAP is not yet a reliable signal.
m40
Margin reset post-merger not fully understood
Gross margin dropped from 60% (2022, pre-merger Primo Water) to ~32% (2024-25) — reflects business-mix change to BlueTriton's bottled-water economics; need to confirm this is the new steady-state, not further compression.
m25
Insider 'buying' is mostly awards
13 of 15 recent transactions are A-Award director grants; only Metropoulos's ~$36K open-market purchases are real P-buys. The 'significant insider buying' label overstates conviction.
This is a real bottled-water franchise with scale and durable cash generation, but it's a leveraged roll-up still digesting a transformational merger — not a fortress. The $310M FCF is the most trustworthy number in the file; the GAAP earnings, the margin structure, and even the share count are all still settling. I don't dock them for the 23.6% diluted share CAGR the way I would for serial SBC abusers (it's deal consideration, and ongoing SBC is tiny), but the per-share math is unimpressive until proven otherwise and the Altman Z of 1.25 is a real constraint. Insider 'buying' is essentially board awards — don't read conviction into it. Solid mid-tier staples operator, not an elite compounder; quality verdict hinges on whether they actually deleverage and whether margins hold.
Verify before trusting this (7)
  • Debt maturity schedule and covenant headroom on the ~$4.74B net debt — when do the merger-financing tranches come due?
  • Confirm 2025 share count is fully post-merger and pro-forma stable (i.e., dilution should stop, not continue at 23%/yr)
  • Synergy targets and realization timeline from the Primo/BlueTriton combination — is the 11% op margin a stepping stone or near-terminal?
  • Sustainability of $310M FCF: capex intensity for route trucks, water rights, and bottling capacity
  • Customer/channel concentration (retail vs. direct-delivery mix) and pricing power vs. private label
  • Any material legal/environmental liabilities tied to bottled-water sourcing (a recurring industry risk)
  • Whether the negative OCF/NI ratio reflects merger purchase-accounting noise that will normalize
-46 Fairly Valued edge √Σ 36 · risk √Σ 82 · conf 6/10
Price $22.95 vs deserved ~$21–24 on quality-adjusted FCF — call it ~0–5% premium, essentially fair. attractive below $18.50

At $22.95 the market cap is ~$8.3B against ~$310M of trustworthy FCF, putting the stock around 27× FCF and ~17–18× on an EV/FCF basis once you add the merger-loaded debt. That's a full multiple for a leveraged roll-up still digesting Primo/BlueTriton, even one with genuine recurring water-delivery cash flows. The e2e read of 'Reasonable Premium' lines up with that: deserved value is close to, not far above, today's print.

The quality lens flags the real catch — 23.6% diluted share CAGR and a leveraged balance sheet — which I use to lower deserved value, not raise it. Combined with the 'Adequate/Mixed' earnings-quality haircut, I won't pay up for GAAP optics that haven't settled. The bull case (consolidation, at-home shift, margin leverage) is plausible but is already the consensus narrative embedded in a 27× FCF multiple; the bear case (commodity water, thin margins, capex) keeps deserved value from running away. Net: no meaningful margin of safety either way. I need a clear discount before this is interesting.

Cheap signals 2
m30
Durable recurring water-delivery FCF deserves a premium
$310M FCF from an essential, subscription-like category is the most trustworthy number in the file and supports a defensible mid-20s multiple — i.e., today's price is not absurd.
m20
Operational leverage optionality not fully credited
If post-merger synergies and at-home mix lift FCF toward $400M+, today's price re-rates to ~21× and looks reasonable rather than full.
Rich / priced-in 3
m55
~27× trailing FCF for a leveraged roll-up
$8.33B cap on ~$310M FCF is ~27×, and EV is higher once merger debt is layered in. That is a staples multiple without staples-quality margins.
m50
Per-share economics diluted by 23.6% share CAGR
The merger-driven share count explosion means even healthy aggregate FCF growth converts into modest per-share growth, which caps the deserved multiple.
m35
Consolidation/margin-leverage story already in the tape
The bull narrative is the consensus narrative; paying 27× FCF means underwriting it as base case with little room for execution slippage on integration.
I read this as fairly priced — a reasonable multiple for a real but leveraged water-delivery franchise that's still settling. I'm not chasing $22.95; the bull narrative is already in the print and the share-count/leverage overhang means I want a real discount, not a fair price. Sub-$19 with FCF holding ~$310M+ is where this becomes a clear buy on valuation; until then it's a watch, not a buy.
Verify before trusting this (5)
  • Run-rate post-synergy FCF guidance and merger integration cost cadence
  • Net debt and leverage ratio trajectory — covenants and refi schedule
  • Organic volume/price split in water delivery vs. retail bottled
  • Diluted share count stabilization — any further equity issuance tied to deals
  • Segment margin disclosure separating delivery (recurring) from retail (commodity)
Two lenses kept deliberately separate — Company Quality is price-agnostic; Valuation is price-conditional. The scores are not blended (yet). Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Community AI Feedback
No community reviews yet for PRMB. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.330 · 344c2a54 · 2026-06-09 20:20:16